mci-196 has been researched along with Hyperlipoproteinemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, C; Saito, Y; Sakurai, K; Todaka, E | 1 |
| Matsuzawa, Y; Nakamura, T | 1 |
1 review(s) available for mci-196 and Hyperlipoproteinemias
| Article | Year |
|---|---|
[Drug treatment of hyperlipoproteinemia: bile acid-binding resins].
Topics: Anticholesteremic Agents; Arteriosclerosis; Bile Acids and Salts; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Liver; Receptors, LDL | 1994 |
1 other study(ies) available for mci-196 and Hyperlipoproteinemias
| Article | Year |
|---|---|
Pilot study to reduce dioxins in the human body.
Topics: Adult; Aged; Anion Exchange Resins; Anticholesteremic Agents; Body Burden; Dioxins; Epichlorohydrin; Female; Humans; Hyperlipoproteinemias; Imidazoles; Male; Middle Aged; Pesticide Residues; Pilot Projects; Resins, Synthetic | 2004 |